Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties
Journal of Medicinal Chemistry – March 20, 2025
Source: OpenAlex
Summary
Revolutionizing psychedelic medicine, new chemical synthesis methods promise easier access to therapeutic compounds. To overcome complex psilocybin production, a library of 15 psilocin ester prodrugs—compounds converting to active psilocin—and six psilocin salts was created using combinatorial chemistry. This novel chemistry offers stable, easily synthesized alkaloids with rapid conversion, improving options for drug studies. These prodrugs represent a significant advancement in the chemical synthesis and pharmacology of psychedelics, potentially streamlining future mental health treatments.
Abstract
As interest in using psilocybin therapy for treating mental health disorders intensifies, the need for efficient production methods becomes increasingly important. Current medical-grade psilocybin production is inefficient and relies on a complicated multistep synthesis. This study has explored and evaluated psilocin ester prodrugs and psilocin salts as potential alternatives to psilocybin, focusing on their ease of synthesis, chemical stability, and metabolic profiles. A diverse library of 15 psilocin ester prodrugs and six psilocin salts was synthesized and evaluated. The study successfully identified several psilocin ester prodrugs and psilocin salts that exhibited desirable characteristics, including storage and handling stability, rapid metabolic conversion to psilocin, and easy synthesis, with potential advantages over psilocybin. This research introduces viable options through psilocin ester compounds and psilocin salts, offering promising avenues for future development.